1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Kinetik reported third-quarter 2025 net income including noncontrolling interest of $15.5 million, down from $83.7 million a year earlier, while total operating revenues rose to $464.0 million from $396.4 million. The company now expects full-year 2025 Adjusted EBITDA of $965 million to $1.005 billion, citing slower Kings Landing ramp-up, producer delays, lower commodity prices, and the October EPIC Crude sale.
Q3 2025 diluted EPS attributable to Class A holders was $0.03, versus $0.35 in Q3 2024
Q3 Adjusted EBITDA was $242.6 million, versus $265.7 million a year earlier
2025 Adjusted EBITDA guidance revised to $965 million to $1.005 billion; 2025 capital guidance tightened to $485 million to $515 million
Closed sale of 27.5% EPIC Crude interest in October 2025 with over $500 million in net upfront cash
Interparfums reported third-quarter 2025 net income attributable to the company of $66 million, or $2.05 per diluted share, up 6% from a year earlier, on net sales of $430 million (up 1%). For the first nine months, net income was flat at $140 million. Management updated 2025 guidance to $1.47 billion in sales (up 1%) and diluted EPS of $5.12 (flat versus 2024), citing slower-than-anticipated growth through September and softer demand in several international markets.
Q3 2025 net sales $430 million, up 1%; diluted EPS $2.05 vs. $1.93 a year earlier
Nine-month net sales $1.10 billion, up 1%; diluted EPS $4.36 vs. $4.34
Updated full-year 2025 guidance: $1.47 billion in sales and $5.12 diluted EPS; 2026 initial guidance due November 18, 2025
Quarterly dividend of $0.80 per share payable December 31, 2025, to holders of record December 15, 2025
Ingevity reported third-quarter 2025 results and revised its full-year 2025 guidance to total net sales of $1.25 billion to $1.35 billion and total adjusted EBITDA of $390 million to $405 million. The company said the revision reflects challenges in its Advanced Polymer Technologies segment, and it reported $43.5 million in net income, including discontinued operations, compared with a net loss of $107.2 million a year earlier.
Net sales from continuing operations were $333.1 million, flat compared with the prior year quarter.
Diluted EPS was $1.18 in the quarter, versus a diluted loss per share of $2.94 a year earlier; continuing operations diluted EPS was $1.10.
Full-year 2025 guidance: total net sales of $1.25 billion to $1.35 billion and total adjusted EBITDA of $390 million to $405 million.
The sale of most of the Industrial Specialties product line and the North Charleston crude tall oil refinery for $110 million is expected to close by early 2026.
Crane NXT reported third quarter 2025 net sales of $445.1 million, up 10.3% from a year earlier, with GAAP EPS of $0.87 versus $0.81 and Adjusted EPS of $1.28 versus $1.16. The company raised its full-year sales growth guidance to 9% to 11% but narrowed its Adjusted EPS guidance to $4.00 to $4.10, down from $4.00 to $4.30 at the top end, citing macroeconomic uncertainty affecting demand in its CPI segment.
Q3 net sales of $445.1 million rose 10.3%, including a $28.3 million benefit from the De La Rue Authentication Solutions acquisition; GAAP EPS was $0.87 versus $0.81.
Adjusted EPS was $1.28 versus $1.16 in the prior-year quarter.
Full-year 2025 sales growth guidance raised to +9% to +11% from +6% to +8%.
Adjusted EPS guidance narrowed to $4.00 to $4.10 from $4.00 to $4.30; quarterly dividend of $0.17 per share is payable December 10, 2025.
Marriott Vacations Worldwide reported a third-quarter 2025 net loss attributable to common stockholders of $2 million, or $0.07 per diluted share, compared with net income of $84 million a year earlier. It also cut its full-year 2025 Adjusted EBITDA and Adjusted free cash flow guidance, while raising the low end of its Adjusted EPS range, which matters to shareholders because the outlook for earnings and cash generation was lowered.
Q3 2025 net loss attributable to common stockholders was $2 million, or $0.07 per diluted share, versus net income of $84 million, or $2.12 per diluted share, in Q3 2024.
Q3 2025 Adjusted EBITDA was $170 million, down 15% from $200 million; consolidated contract sales were $439 million, down 4%.
Full-year 2025 Adjusted EBITDA guidance is $740 million to $755 million, down from $750 million to $780 million; Adjusted free cash flow guidance is $235 million to $270 million, down from $270 million to $330 million.
Full-year 2025 Adjusted EPS guidance is $6.70 to $7.10, up from $6.40 to $7.10; the company will hold a conference call on November 6, 2025 at 8:30 a.m. ET.
Q2 Holdings reported third-quarter 2025 revenue of $201.7 million, up 15 percent year over year, and GAAP net income of $15.0 million, compared with a net loss of $11.8 million a year earlier. The company raised its full-year 2025 revenue and adjusted EBITDA guidance and authorized up to $150 million in share repurchases, which it expects to fund from existing cash. Shareholders also face an executive change, as the chief revenue officer will leave on December 12, 2025.
Q3 2025 revenue was $201.7 million, up 15 percent year over year; GAAP net income was $15.0 million, or $0.23 diluted EPS, versus a net loss of $11.8 million a year earlier
Adjusted EBITDA was $48.8 million, up from $32.6 million in the prior-year quarter
Full-year 2025 guidance raised to revenue of $789.0 million to $793.0 million and adjusted EBITDA of $182.5 million to $185.5 million
Board authorized repurchases of up to $150 million of common stock with no expiration date; Chief Revenue Officer Mike Volanoski will depart effective December 12, 2025
Tutor Perini reported third-quarter 2025 revenue of $1.42 billion, up 31% from $1.08 billion a year earlier, and swung to diluted earnings of $0.07 per share from a loss of $1.92 per share. The company raised its 2025 Adjusted EPS guidance to $4.00 to $4.20 from $3.65 to $3.95, its third consecutive increase, and reported a record backlog of $21.6 billion.
Q3 2025 revenue of $1.42 billion, up 31% from $1.08 billion in Q3 2024
Diluted EPS of $0.07 versus a loss of $1.92 a year earlier; Adjusted EPS of $1.15 versus an adjusted loss of $1.61
2025 Adjusted EPS guidance raised to $4.00 to $4.20 from $3.65 to $3.95; GAAP EPS guidance no longer provided
Record backlog of $21.6 billion at September 30, 2025, up 54%; Q3 operating cash flow of $289.1 million
CoreCivic reported third-quarter 2025 revenue of $580.4 million, up 18.1% from a year earlier, and net income of $26.3 million, or $0.24 per diluted share. It lowered its full-year 2025 guidance, citing start-up expenses at four newly contracted facilities that it expects to weigh on fourth-quarter results, while saying those facilities should support stronger 2026 results.
Q3 2025 net income was $26.3 million, or $0.24 per diluted share, compared with $21.1 million, or $0.19, in Q3 2024.
Full-year 2025 net income guidance was revised to $107.0 million to $113.0 million, down from $116.4 million to $124.4 million.
Full-year 2025 adjusted EBITDA guidance was revised to $355.0 million to $359.0 million, down from $365.0 million to $371.0 million.
In Q3 2025 the company repurchased 1.9 million shares for $40.0 million; $197.9 million of repurchase authorization remained as of September 30, 2025.
Pursuit Attractions and Hospitality reported third quarter 2025 revenue of $241.0 million, up 32.2% from a year earlier, and net income attributable to Pursuit of $73.9 million, versus $48.6 million. The company raised its full-year 2025 adjusted EBITDA guidance to $116 million to $122 million, an increase of $6 million at the midpoint, which points to higher expected profit for shareholders.
Q3 2025 revenue was $241.0 million, up $58.8 million from $182.3 million in Q3 2024.
Diluted EPS attributable to Pursuit was $2.60, versus $1.65; adjusted EBITDA was $117.4 million, versus $82.9 million.
Full-year 2025 adjusted EBITDA guidance was raised to $116 million to $122 million from $108 million to $118 million.
Q3 results included a $4.2 million pre-tax gain from business interruption insurance proceeds tied to the 2024 Jasper wildfire.
Acadia Healthcare reported third-quarter 2025 revenue of $851.6 million, up 4.4% year over year, but diluted earnings per share fell to $0.40 from $0.74 and adjusted EBITDA fell to $173.0 million from $194.3 million. The company lowered its full-year 2025 revenue, adjusted EBITDA and adjusted EPS guidance, and COO Dr. Nasser Khan resigned effective November 3, 2025.
Q3 revenue $851.6 million, up 4.4%; same-facility admissions up 3.3%
Net income attributable to Acadia $36.2 million, or $0.40 per diluted share, vs $0.74 a year earlier
Full-year adjusted EBITDA guidance cut to $650 million to $660 million from $675 million to $700 million
Dr. Nasser Khan resigned as COO effective November 3, 2025; receives a $515,000 lump-sum payment by March 15, 2026
Schrödinger reported third-quarter 2025 total revenue of $54.3 million, up 54% from a year earlier, and a net loss of $32.8 million, narrower than the $38.1 million loss in the prior-year quarter. The company lowered its full-year 2025 software revenue growth guidance to 8% to 13% from 10% to 15%, and said it expects savings of approximately $70 million from expense-reduction measures and a shift away from independent clinical development.
Q3 total revenue was $54.3 million, up 54%; software revenue was $40.9 million, up 28%, and drug discovery revenue was $13.5 million versus $3.4 million a year earlier.
Full-year 2025 software revenue growth guidance was cut to 8% to 13% from 10% to 15%, while drug discovery revenue guidance was raised to $49 million to $52 million from $45 million to $50 million.
Q3 net loss was $32.8 million, versus $38.1 million in Q3 2024; non-GAAP net loss was $42.3 million.
Cash, cash equivalents, restricted cash and marketable securities totaled $401.0 million at September 30, 2025.
Essential Utilities reported third-quarter 2025 net income of $92.1 million, or $0.33 per share, up from $69.4 million, or $0.25 per share, a year earlier, on revenue that rose 9.6% to $477.0 million. The company now expects 2025 GAAP earnings per share above its prior $2.07-$2.11 guidance range, citing non-recurring benefits, and reaffirmed its long-term guidance, which matters to shareholders because it signals stronger reported earnings for the year.
Q3 2025 net income was $92.1 million, or $0.33 per share, versus $69.4 million, or $0.25 per share, in Q3 2024.
Revenue for the quarter was $477.0 million, up 9.6%, mainly from rate increases.
For 2025, GAAP earnings per share are expected to be above the prior $2.07-$2.11 range due to non-recurring benefits.
The pending merger with American Water Works, announced October 27, 2025, is expected to close by the end of the first quarter of 2027.
Trimble reported third-quarter 2025 revenue of $901.2 million, up 3% from $875.8 million a year earlier, and GAAP diluted earnings per share of $0.46 versus $0.16. The company raised its full-year 2025 guidance, now expecting revenue of $3,545 million to $3,585 million and non-GAAP earnings per share of $3.04 to $3.12.
Q3 2025 revenue was $901.2 million, up 3% from $875.8 million; up 10% on an organic basis.
Diluted EPS was $0.46 on a GAAP basis, versus $0.16 a year earlier, and $0.81 non-GAAP, versus $0.70.
Full-year 2025 guidance: revenue of $3,545 million to $3,585 million and non-GAAP EPS of $3.04 to $3.12.
Fourth-quarter 2025 guidance: revenue of $927 million to $967 million and non-GAAP EPS of $0.91 to $0.99.
Astec Industries reported third-quarter 2025 net sales of $350.1 million, up 20.1% from a year earlier, helped by the July 1, 2025 TerraSource acquisition. The company posted a net loss of $4.2 million, compared with a $6.2 million loss a year earlier, and adjusted EPS of $0.47 versus $0.36. It also raised the low end of its full-year adjusted EBITDA guidance to $132 million from $123 million, with the top end unchanged at $142 million.
Q3 net sales were $350.1 million, up 20.1%; Infrastructure Solutions rose 17.1% to $193.2 million and Materials Solutions rose 24.1% to $156.9 million.
Net loss attributable to the controlling interest was $4.2 million, or $(0.18) per diluted share, versus a $6.2 million loss, or $(0.27), a year earlier.
Adjusted EBITDA was $27.1 million, up 55.7% from $17.4 million; transaction costs of $8.3 million weighed on GAAP results.
Full-year 2025 adjusted EBITDA guidance is now $132 million to $142 million, with the low end raised from $123 million.
Perrigo reported third-quarter 2025 net sales of $1.04 billion, down 4.1% year over year, and adjusted diluted EPS of $0.80 versus $0.81 a year earlier. The company lowered its full-year 2025 outlook, now projecting adjusted diluted EPS of $2.70 to $2.80 and reported net sales growth of -2.5% to -3.0%, citing infant formula industry dynamics and soft OTC consumption. It also said it is starting a strategic review of its infant formula business, adding to the existing review of Oral Care.
Q3 2025 net sales were $1.04 billion, down 4.1%; reported diluted EPS was $0.09 versus a loss of $(0.13) a year earlier
Q3 2025 adjusted diluted EPS was $0.80, down from $0.81; adjusted operating income was $173 million, down 4.9%
Full-year 2025 outlook revised: adjusted diluted EPS of $2.70 to $2.80 and reported net sales growth of -2.5% to -3.0%
Strategic review of the infant formula business announced November 5, 2025; Oral Care review continues and Dermacosmetics sale is expected to close in Q1 2026
Fortrea reported third-quarter 2025 revenue of $701.3 million, up from $674.9 million a year earlier, while adjusted EBITDA fell to $50.7 million from $64.2 million. The company raised its full-year 2025 revenue guidance and narrowed its adjusted EBITDA guidance, so shareholders see higher sales expectations alongside lower quarterly profit measures.
Q3 2025 revenue was $701.3 million versus $674.9 million in Q3 2024.
Q3 GAAP diluted loss per share was $(0.17) versus $(0.21); adjusted diluted EPS was $0.12 versus $0.23.
Q3 adjusted EBITDA was $50.7 million versus $64.2 million in Q3 2024.
2025 revenue guidance raised to $2.70 billion to $2.75 billion; adjusted EBITDA guidance narrowed to $175 million to $195 million.
Elanco reported third-quarter 2025 revenue of $1,137 million, up 10% from a year earlier, and raised its full-year 2025 revenue and adjusted EBITDA guidance. The company posted a reported net loss of $34 million, compared with net income of $364 million a year earlier that included a gain on the aqua divestiture, though adjusted EPS rose 46% to $0.19. For shareholders, the higher operating outlook points to stronger sales momentum, while the reported net loss guidance was also widened.
Q3 2025 revenue was $1,137 million, up 10% reported and 9% organic constant currency.
Reported net loss was $34 million, or $(0.07) per share, versus net income of $364 million a year earlier; adjusted EPS was $0.19, up 46%.
Full-year revenue guidance was raised to $4,645 million to $4,670 million from $4,570 million to $4,620 million; adjusted EBITDA guidance rose to $880 million to $900 million from $850 million to $890 million.
Full-year reported net loss guidance widened to $(56) million to $(41) million from $(38) million to $(14) million.
LivaNova reported third-quarter 2025 revenue of $357.8 million, up 12.5% from a year earlier, and raised its full-year 2025 adjusted diluted EPS guidance to $3.80 to $3.90. GAAP diluted EPS fell to $0.49 from $0.60, and the nine-month GAAP net loss of $273.4 million reflects a $363.8 million SNIA environmental liability expense.
Q3 2025 revenue $357.8 million vs $318.1 million a year earlier
Q3 GAAP diluted EPS $0.49 vs $0.60; adjusted diluted EPS $1.11 vs $0.90
2025 adjusted diluted EPS guidance raised to $3.80 to $3.90 from $3.70 to $3.80
Nine-month GAAP net loss $273.4 million, including $363.8 million SNIA environmental liability expense
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.